Genesco Inc. (NYSE: GCO) reports results for the fourth quarter of 2019 on March 14, 2019, before the market opens. Net sales from continuing operations slipped 2% in the quarter to $675 million from $689 million in the fourth quarter of fiscal 2018. If the extra week’s revenue from last year’s 14-week quarter and the impact of lower exchange rates this year were excluded, revenue was up 4%.
Net loss for the three-month period was $3.29 per diluted share, compared to a profit of $2.90 per share last year.
Comparable sales from continuing operations fell 4%, with stores up 3% and direct up 10%.
GAAP earnings from continuing operations fell to $29.7 million, from last year’s $48.4 million Adjusted earnings from continuing operations grew to $42.4 million from $35.7 million a year ago.
Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
